An interventional study of High energy density enteral nutrition and General energy density enteral nutrition in Congenital Heart Disease, Enteral Nutrition and Pediatrics, sponsored by Children's Hospital of Fudan University. Recruiting at 1 site in China. Open to participants aged 0 Months to 6 Months. Per ClinicalTrials.gov, last updated 2026-05-13.
Sponsored by Children's Hospital of Fudan University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Heart Defects, Congenital by Children's Hospital of Fudan University — 3 open to participants now, 3 under way, none of them phase 3. Heart Defects, Congenital · Children's Hospital of Fudan University.
Among the 14 studies in Heart Defects, Congenital by Children's Hospital of Fudan University, this one is one of 3 that started in 2025, is one of 7 with no phase, and was the 12th registered.
992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.
Browse Heart Defects, Congenital studies →3 of the 14 studies in Heart Defects, Congenital by Children's Hospital of Fudan University are open now, in 1 country. Recruiting first, the newest first:
Children's Hospital of Fudan University · Sites in China
Ages 1 wk–18 yrs
Children's Hospital of Fudan University
Ages 6 hrs–72 hrs · Healthy volunteers
By country, each count listing its studies:
Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.
This study: 0 Months to 6 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 160 is above the median of 60 across 508 interventional studies indexed under Heart Defects, Congenital.
Median enrollment 110 across the 8 interventional studies, 6,150 across the 6 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Children's Hospital of Fudan University is the lead sponsor of 268 studies on the registry; 94 are open to participants now.
3 of the studies in Heart Defects, Congenital by Children's Hospital of Fudan University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07115108Children's Hospital of Fudan UniversityEffectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease | 2026-12-31 |
| NCT06747546Children's Hospital of Fudan UniversityResearch on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery | 2026-12-31 |
| NCT07901998Children's Hospital of Fudan UniversityOptimization of Two-Indicator Screening Protocol for Neonatal Congenital Heart Disease at High Altitude | 2027-11 |
Add all 3 to your calendar (.ics) → With an account.
Among the 14 studies in Heart Defects, Congenital by Children's Hospital of Fudan University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to compare the effect of high and ordinary energy density enteral nutrition for improving physical growth and brain cognitive development in infants with congenital heart disease after operation, as well as evaluate the safety of interventions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
High-energy-density enteral nutrition (100 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted. Weight measurements and neurological assessments will be conducted at admission, prior to discharge, and at 1-, 3-, and 6-month intervals post-discharge. The safety of the intervention will be closely monitored throughout the study period.
Dietary Supplement: High energy density enteral nutrition
General energy density enteral nutrition (60-88cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted. Weight measurements and neurological assessments will be conducted at admission, prior to discharge, and at 1-, 3-, and 6-month intervals post-discharge. The safety of the intervention will be closely monitored throughout the study period.
Dietary Supplement: General energy density enteral nutrition
High-energy-density enteral nutrition (100 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted.
Also known as: High energy density EN
General energy density enteral nutrition (60-88 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted.
Also known as: General energy density EN
Weight-for-age z score (WAZ)
WAZ is calculated according to the Chinese child growth curve and cut-offs .It is a statistical index used to assess the nutritional status of children. The physical examination will be conducted by a nurse, and the data will be recorded to one decimal place.
Time frame: 6th month after discharge
Weight-for-age z score (WAZ)
WAZ is calculated according to the Chinese child growth curve and cut-offs .It is a statistical index used to assess the nutritional status of children. The physical examination will be conducted by a nurse, and the data will be recorded to one decimal place.
Time frame: Before discharge, 1st month, 3rd month after discharge
Cognitive development
The Griffiths mental development scales (GMDs) will be used to repeatedly measure the indicators .The Griffiths scales typically yield a Developmental Quotient (DQ) with an average range of 85-115. The higher the scores, the more advanced development relative to age norms in assessed domains (e.g., motor, language, or cognition).
Time frame: Before discharge, 1st month, 3rd month, 6th month after discharge
Incidence of subjects with Gastrointestinal mucosal barrier function injury
Primarily defined by elevation in fecal calprotectin and Inflammatory cytokines level.The reference range for calprotectin is 0-5 μg/g,inflammatory cytokines is ≤20pg/ml.Exceeding this range will be considered as abnormal gastrointestinal mucosal barrier function.
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Albumin level
Albumin is a rich protein in the blood, which mainly reflects the nutritional status.The reference range for albumin is 39-54g/L.If it is not within this range, it will be judged as abnormal.
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Blood lipid levels
Blood lipid test is to measure the content of lipids in blood.Blood lipids include total cholesterol(0-5.18mmol/L) and triglycerides(0-1.7mmol/L).If it exceeds the range, it will be considered as abnormal.
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Energy intake (cal/d)
Calculate the caloric intake for enteral feeding according to the Schofeld formula recommended by the European Society for Pediatric and Neonatal Intensive Care (ESPNIC)
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Enteral Nutrition intake (ml/d)
Based on the child's weight and the fluid balance in the previous 24 hours, the total fluid intake for the day is calculated. After subtracting the amount of intravenous drug solution, the amount of enteral nutrition formula is obtained. According to the child's gastrointestinal function, the principle of gradual progress is adopted to rationally allocate the single feeding volume and feeding frequency.
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Incidence of malabsorption
Incidence of malabsorption (as defined by any of the following criteria): abnormal fecal lactose content; abnormal fecal fat content.The diagnosis will be confirmed by fecal examination.
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Incidence of feeding intolerance
Any of the following condition: 1. Frequent vomiting (≥ 3 times/d); 2.Abdominal distension; 3. Milk volume did not increase or decreased\>3 d; 4. Gastric retention (retention\>1/3 of the previous feeding); 5. Unplanned discontinuation of feeding ≥ 2 times; 6. Diarrhea (stool frequency\>6 times/d)
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Incidence of necrotizing enterocolitis(NEC)
NEC diagnosed in stage II and III will be recorded.
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Other surgical indications
Mechanical ventilation time (days), postoperative CCU hospitalization duration (days), total hospitalization duration (days), hospitalization costs (Yuan), and the incidence of poor wound healing will be recorded.
Time frame: At the day of discharge, an average of 3 week after surgery
Started Oct 2025 (actual). Primary completion is estimated for Dec 2026, 14 months after the start.
Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 14 months is below that.
Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Fudan University →